{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
China Pharma Holdings, Inc.
Is China Pharma Holdings, Inc. technically bullish or bearish?
As of June 13, 2025, the trend is mildly bearish due to bearish signals from the weekly MACD and Bollinger Bands, despite some mildly bullish indications from the monthly MACD and KST.
Who are in the management team of China Pharma Holdings, Inc.?
As of March 2022, the management team of China Pharma Holdings, Inc. includes Zhilin Li (Chairman, President, CEO, Interim CFO), Heung Tsui (Director), and independent directors Gene Bennett, Baowen Dong, and Yingwen Zhang. They oversee the company's operations and strategic direction.
What does China Pharma Holdings, Inc. do?
China Pharma Holdings, Inc. is a micro-cap holding company focused on developing, manufacturing, and marketing pharmaceutical products for human use. As of March 2025, it reported net sales of $1 million and a net loss of $1 million, with a market cap of $5.97 million.
How big is China Pharma Holdings, Inc.?
As of Jun 18, China Pharma Holdings, Inc. has a market capitalization of 5.97 million and reported net sales of 4.29 million with a net profit of -4.57 million over the latest four quarters.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
